organization · Reporting owner
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Silver Point Specialty Lending FundN/A · Entity 43278 | 10% owner | May 01, 2026 | May 29, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Silver Point Specialty Lending Fund
Report date May 01, 2026 · Filed May 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| COMMON SHARESSEC Table I · non-derivative | Direct | 4,283,063.6581 |
Reported balance
After 2026-05-01 transaction · row 1
1 source rowRow 1 · 2026-05-01 · Purchase · Acquired 47,481.3571 · Balance 4,283,063.6581 F1: Shares acquired pursuant to a capital call under the issuer partnership agreement. Capital call occurred on 05.01.2026 and the confirmation of shares and share price occurred on 05.28.2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares acquired pursuant to a capital call under the issuer partnership agreement. Capital call occurred on 05.01.2026 and the confirmation of shares and share price occurred on 05.28.2026.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Rein Therapeutics, Inc.
Report date June 14, 2024 · Filed June 17, 2024
Section 16 reporting ended · disclosed 2024-06-17. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,746,549 |
Last balance in matching sequence
After 2024-06-17 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2024-06-14 · Sale · Disposed 1,900 · Balance 1,751,256 F1: Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents. Row 2 · 2024-06-17 · Sale · Disposed 4,707 · Balance 1,746,549 F1: Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 01, 2024 Filed May 14, 2024 21:54 UTC Amendment | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 100 | $4.11 | $411.00 |
DisclosureSEC source: 0001019231-24-000023 · primary_doc.xml · nonDerivative · entry 2 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO · CIK 0001019231 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,807,257 F1 · ownership.direct: Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents. Read SEC document |
| May 01, 2024 Filed May 14, 2024 21:54 UTC Amendment | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 3,100 | $4.10 | $12,710.00 |
DisclosureSEC source: 0001019231-24-000023 · primary_doc.xml · nonDerivative · entry 1 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO · CIK 0001019231 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,807,357 F1 · ownership.direct: Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents. Read SEC document |
| April 30, 2024 Filed May 1, 2024 23:15 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 45 | $5.00 | $225.00 |
DisclosureSEC source: 0001019231-24-000022 · primary_doc.xml · nonDerivative · entry 8 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO · CIK 0001019231 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,799,621 F1 · ownership.direct: Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents. Read SEC document |
| April 30, 2024 Filed May 1, 2024 23:15 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 45 | $4.95 | $222.75 |
DisclosureSEC source: 0001019231-24-000022 · primary_doc.xml · nonDerivative · entry 7 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO · CIK 0001019231 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,799,666 F1 · ownership.direct: Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents. Read SEC document |
| April 29, 2024 Filed May 1, 2024 23:15 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 448 | $5.03 | $2,251.20 |
DisclosureSEC source: 0001019231-24-000022 · primary_doc.xml · nonDerivative · entry 6 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO · CIK 0001019231 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,799,711 F1 · ownership.direct: Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents. Read SEC document |
| April 29, 2024 Filed May 1, 2024 23:15 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 13 | $5.01 | $65.07 |
DisclosureSEC source: 0001019231-24-000022 · primary_doc.xml · nonDerivative · entry 5 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO · CIK 0001019231 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,800,159 F1 · ownership.direct: Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents. Read SEC document |
| April 29, 2024 Filed May 1, 2024 23:15 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 3,231 | $5.00 | $16,155.00 |
DisclosureSEC source: 0001019231-24-000022 · primary_doc.xml · nonDerivative · entry 4 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO · CIK 0001019231 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,800,172 F1 · ownership.direct: Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents. Read SEC document |
| April 29, 2024 Filed May 1, 2024 23:15 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 100 | $4.94 | $494.00 |
DisclosureSEC source: 0001019231-24-000022 · primary_doc.xml · nonDerivative · entry 3 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO · CIK 0001019231 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,803,403 F1 · ownership.direct: Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents. Read SEC document |
| April 29, 2024 Filed May 1, 2024 23:15 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 274 | $4.93 | $1,350.82 |
DisclosureSEC source: 0001019231-24-000022 · primary_doc.xml · nonDerivative · entry 2 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO · CIK 0001019231 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,803,503 F1 · ownership.direct: Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents. Read SEC document |
| April 29, 2024 Filed May 1, 2024 23:15 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 6,680 | $4.92 | $32,865.60 |
DisclosureSEC source: 0001019231-24-000022 · primary_doc.xml · nonDerivative · entry 1 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO · CIK 0001019231 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,803,777 F1 · ownership.direct: Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.